A new PET tracer designed to target melanin pigment could improve the detection of both primary and metastatic melanoma, according to a study published in the January issue of the Journal of Nuclear Medicine. {read more here}
For the study, published in Radiology, researchers fed PET brain scans to a machine-learning algorithm, and it learned to diagnose early-stage Alzheimer’s disease about six years before a clinical diagnosis could be made. {read more here}
Radiolabeled 18F-fluoride PET/CT proved superior at detecting bone metastases (BM) than a comparative radiotracer, according to a Jan.14 study published in Clinical Radiology. {read more here}
Tau and amyloid levels were also tracked in all subjects using either PET scans or spinal fluid sampling. The results revealed that those subjects suffering from lower levels of slow-wave sleep displayed higher volumes of tau protein in the brain. {read more here}